STATE STREET CORP - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 34 filers reported holding AIM IMMUNOTECH INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$78,762
-32.1%
173,1030.0%0.00%
Q2 2023$115,979
+55.8%
173,1030.0%0.00%
Q1 2023$74,434
-31.1%
173,103
-50.0%
0.00%
Q4 2022$107,982
+6.9%
346,206
+100.0%
0.00%
Q3 2022$101,000
-25.2%
173,1030.0%0.00%
Q2 2022$135,000
-26.2%
173,1030.0%0.00%
Q1 2022$183,000
+23.6%
173,103
+7.9%
0.00%
Q4 2021$148,000
-54.3%
160,4130.0%0.00%
Q3 2021$324,000
-6.1%
160,4130.0%0.00%
Q2 2021$345,000160,4130.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2023
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders